![]() |
Volumn 158, Issue 4, 2001, Pages 518-526
|
Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: A review and meta-analysis of randomized trials
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHLORPROMAZINE;
CLOZAPINE;
HALOPERIDOL;
NEUROLEPTIC AGENT;
OLANZAPINE;
RISPERIDONE;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
ENURESIS;
EXTRAPYRAMIDAL SYMPTOM;
HUMAN;
MENTAL DISEASE;
META ANALYSIS;
NEGATIVE SYNDROME;
NEUROLEPTIC MALIGNANT SYNDROME;
NEUTROPENIA;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
RATING SCALE;
REVIEW;
SCHIZOPHRENIA;
SCORING SYSTEM;
SEDATION;
SEIZURE;
TARDIVE DYSKINESIA;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
AGE OF ONSET;
ANTIPSYCHOTIC AGENTS;
BRIEF PSYCHIATRIC RATING SCALE;
CLOZAPINE;
FEMALE;
HUMANS;
MALE;
PSYCHIATRIC STATUS RATING SCALES;
RANDOMIZED CONTROLLED TRIALS;
SCHIZOPHRENIA;
SCHIZOPHRENIC PSYCHOLOGY;
TREATMENT OUTCOME;
|
EID: 0035065899
PISSN: 0002953X
EISSN: None
Source Type: Journal
DOI: 10.1176/appi.ajp.158.4.518 Document Type: Review |
Times cited : (567)
|
References (38)
|